HomeINCY • NASDAQ
add
Incyte Corp
Nakaraang pagsara
$73.13
Sakop ng araw
$69.53 - $72.60
Sakop ng taon
$50.35 - $83.94
Market cap
13.59B USD
Average na Volume
1.79M
P/E ratio
504.04
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.14B | 23.81% |
Gastos sa pagpapatakbo | 308.47M | 15.48% |
Net na kita | 106.46M | -37.84% |
Net profit margin | 9.36 | -49.79% |
Kita sa bawat share | 1.07 | -2.73% |
EBITDA | 192.75M | -18.48% |
Aktuwal na % ng binabayarang buwis | 31.99% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.77B | -49.53% |
Kabuuang asset | 5.01B | -21.54% |
Kabuuang sagutin | 1.84B | 26.39% |
Kabuuang equity | 3.17B | — |
Natitirang share | 192.65M | — |
Presyo para makapag-book | 4.45 | — |
Return on assets | 8.80% | — |
Return on capital | 13.64% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 106.46M | -37.84% |
Cash mula sa mga operasyon | 310.87M | 110.28% |
Cash mula sa pag-invest | 38.27M | 322.67% |
Cash mula sa financing | -32.35M | 13.17% |
Net change in cash | 316.92M | 229.77% |
Malayang cash flow | 367.45M | 138.29% |
Tungkol
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware, and Morges, Switzerland.
The company was created in 2002 through the merger of Incyte Pharmaceuticals, founded in Palo Alto, California in 1991 and Incyte Genomics, Inc. of Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufacturers prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
Itinatag
2002
Headquarters
Website
Mga Empleyado
2,524
